Innovation

Alpha synuclein can be used as a novel biomarker for detection of melanoma

Medical College of Georgia
posted on 11/22/2010

The researchers have discovered a novel method whereby a-synuclein can be used to detect the presence of specific melanoma type cells present in skin cancer patients. The discovery can be used as an additional test when performing skin biopsies of melanoma cells.


Innovation Details
 

File Number: MCG 2010-031 


IP Protection


License Online

This innovation currently is not available for online licensing. Please contact Kourosh Sabet-Payman at Medical College of Georgia for more information.

Request more info via email request more info
People

Case Manager:

Kourosh Sabet-Payman Kourosh Sabet-Payman

Innovations (0)

Download Technology Brief (PDF)


[?]
Followed By

Follow this innovation



No one is following this innovation.

Organization
8081

Medical College of Georgia


Profile
Related Tags

Find more innovations

February 11, 2009

8,793 members 16,677 innovations 159 organizations

Browse

Scott Steele, coordinator of the CTSA-IP initiative and director of research alliances at the University of Rochester

"With more than 3,700 innovations from CTSA member institutions already on the iBridge Network, we're garnering worldwide exposure for the breakthroughs our researchers are accomplishing while moving toward our goal of increasing human health through clinical and translational research."  read more...